PACS Group (NYSE:PACS) Raised to Buy at Wall Street Zen

PACS Group (NYSE:PACS) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday.

Other equities research analysts have also issued reports about the company. Royal Bank Of Canada boosted their target price on PACS Group from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Thursday. Weiss Ratings raised shares of PACS Group from a “sell (d)” rating to a “hold (c-)” rating in a report on Thursday. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, PACS Group currently has a consensus rating of “Moderate Buy” and an average price target of $26.75.

PACS Group Trading Up 5.4%

Shares of NYSE:PACS opened at $27.54 on Friday. The stock has a market capitalization of $4.31 billion, a PE ratio of 88.84 and a beta of 1.05. PACS Group has a 1 year low of $7.50 and a 1 year high of $27.78. The firm has a fifty day moving average price of $13.30 and a 200 day moving average price of $12.01.

PACS Group (NYSE:PACS) last announced its quarterly earnings results on Wednesday, November 19th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.46 by ($0.14). The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.11 billion. PACS Group had a return on equity of 21.39% and a net margin of 3.29%. PACS Group has set its FY 2025 guidance at EPS. On average, sell-side analysts forecast that PACS Group will post 1.01 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of PACS. PharVision Advisers LLC bought a new stake in shares of PACS Group in the third quarter valued at approximately $200,000. Zimmer Partners LP raised its stake in PACS Group by 27.4% during the 3rd quarter. Zimmer Partners LP now owns 302,500 shares of the company’s stock valued at $4,153,000 after purchasing an additional 65,000 shares during the last quarter. Alyeska Investment Group L.P. bought a new stake in PACS Group in the 3rd quarter valued at $11,904,000. Verition Fund Management LLC boosted its holdings in PACS Group by 9.9% in the 3rd quarter. Verition Fund Management LLC now owns 39,783 shares of the company’s stock valued at $546,000 after purchasing an additional 3,599 shares during the period. Finally, Quarry LP grew its position in PACS Group by 79.5% in the 3rd quarter. Quarry LP now owns 2,388 shares of the company’s stock worth $33,000 after purchasing an additional 1,058 shares during the last quarter.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.